ACCESS THE LATEST RESEARCH AND INSIGHTS
Musk Joins Cannabis Craze
Elon Musk had quite the experience on the Joe Rogan Experience podcast.
Musk Joins Cannabis Craze
Elon Musk had quite the experience on the Joe Rogan Experience podcast.
Bull Market Peak May be Two Years Away
This indicator shows why the bull market peak may be two years away.
Bull Market Peak May be Two Years Away
This indicator shows why the bull market peak may be two years away.
Maxar “Sharply Mispriced” with 127% Upside
Keep reading to find out why RBC says investors should be buyers of Maxar Technologies.
Maxar “Sharply Mispriced” with 127% Upside
Keep reading to find out why RBC says investors should be buyers of Maxar Technologies.
This Company Has “Breakthrough” Technology and 170% Upside
Also inside: New coverage of an international energy company that could more than double.
Plus: An update on a Fabrice Taylor cannabis favourite.
This Company Has “Breakthrough” Technology and 170% Upside
Also inside: New coverage of an international energy company that could more than double.
Plus: An update on a Fabrice Taylor cannabis favourite.
This Stock No Turkey with 112% Upside
Keep reading for research on a company with a “large-scale asset and takeout potential”.
This Stock No Turkey with 112% Upside
Keep reading for research on a company with a “large-scale asset and takeout potential”.
Cronos Group “Buy on Weakness”
Cronos Group CEO Michael Gorenstein was all smiles when we interviewed him a few months ago. But the company’s stock dropped nearly 30% on Thursday on a short seller’s report. Keep reading to see what analysts are saying.
Cronos Group “Buy on Weakness”
Cronos Group CEO Michael Gorenstein was all smiles when we interviewed him a few months ago. But the company’s stock dropped nearly 30% on Thursday on a short seller’s report. Keep reading to see what analysts are saying.
Morning Need to Know – 30th August 2018
And, we’re back. Good morning!
Be sure to take advantage of the 30-Day Free Trial from 5i Research to access all of their independent, in-depth, conflict-free company reports.
Keep reading for advice on how to make money in cannabis stocks.
Morning Need to Know – 30th August 2018
And, we’re back. Good morning!
Be sure to take advantage of the 30-Day Free Trial from 5i Research to access all of their independent, in-depth, conflict-free company reports.
Keep reading for advice on how to make money in cannabis stocks.
5i Research New Coverage of Recession Proof Stock
Why 5i Research is adding this company with a good management track record and a strong balance sheet to its Income Portfolio.
5i Research New Coverage of Recession Proof Stock
Why 5i Research is adding this company with a good management track record and a strong balance sheet to its Income Portfolio.